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Recently, ithasbeendemonstrated that immunity to infec-
tious agents is composed of innate immunity and acquired
immunity, and that dendritic cells (DC) andmacrophages,
both of which are the participants in the innate immunity,
play a crucial role in acquired immune responses, via their
expressionof several costimulatorymolecules andproduc-
tion of cytokines. It is clear that the immune system
responds not only to infectious organisms but also to
simple chemicals. Allergic contact hypersensitivity reac-
tion is a good example of the immune response to simple
Two principal systems of immunity to infectious agentshave been selected during evolution: (a) innate ornatural immunity, and (b) acquired (adaptive) or specificimmunity (Fig 1) (Fearon and Locksley, 1996; Medzhi-tov and Janeway, 1997; Janeway, 1998). Innate immunity
is phylogenetically older than acquired immunity. The essential differ-
ence between the two systems is the means by which they recognize
microorganisms. The innate immunity system uses proteins encoded
in the germ line to identify potentially noxious substances. These
proteins usually seem to recognize carbohydrate structures. For example,
macrophages endocytose particles or soluble glycoconjugates that are
bound by the mannose receptor, a C-type lectin with broad carbohyd-
rate specificity. In addition, they also have a receptor for lipopolysaccha-
ride. On the other hand, using products of the RAG1 and RAG2
genes, B and T lymphocytes somatically rearrange the V, D, and J
elements of their immunoglobulin and T cell receptor genes, respect-
ively, to create as many as 1011 different clones of B or T lymphocytes
that express distinct antigen receptors. Therefore, the innate immune
system is inflexible in its recognition of targets, whereas the acquired
immune system of lymphocytes is almost infinitely adaptable.
Using this highly adaptable system, however, acquired immunity
has sacrificed a cardinal characteristic of innate immunity; the inherent
ability to distinguish between potential pathogens that require an
immune response and innocuous substances for which an immune
response is either unnecessary or, in the case of self-antigen, rather
injurious. Here innate immunity provides instruction that enables
the acquired immune response to select appropriate antigens and
eliminate them
For example, in the two-signal model of T cell activation (Kaye,
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chemicals. In contrast to the immunity to microorgan-
isms, however, the role of the innate immune system in
responses to simple chemicals still remains unclear. This
paper demonstrates that the activation and apoptosis of
DC are directly induced by certain simple chemicals, and
we suggest that DC, as cells involved in the innate immune
system,play acrucial role in the immunity to simple chem-
icals. Key words: contact hypersensitivity/costimulatory
molecules/hapten/innate immunity. Journal of Investigative
Dermatology Symposium Proceedings 4:158–163, 1999
1995), T cell receptor ligation by major histocompatibility complex
(MHC)-antigen provides signal 1, which is a primary activation signal
mediated via the activation of protein tyrosine kinases, requiring the
CD45 protein tyrosine phosphatase. Signal 2 is achieved by the
interaction of a variety of receptor-counter receptor pairs, of which
the best characterized are those involving CD80/CD86 and CD28/
CTLA-4, which utilize biochemical pathways distinct from those
initiated by the T cell receptor (TCR). The immunoregulatory
potential of costimulation becomes clear when it is shown that TCR
ligation in the absence of signal 2 could lead to T cell nonresponsiveness
or anergy. This signal 2 is supplied by innate immunity, including
various antigen-presenting cells (APC).
Among the various APC, dendritic cells (DC) are the most potent
ones for helper T cells as well as cytotoxic T cells (Steinman, 1991).
After their development in the bone marrow, they transiently reside
in nonlymphoid organs where they are extremely active in endocytosis
as well as in antigen processing (Romani et al, 1989a). In response to
some stimuli derived from microorganisms, such as lipopolysaccharide
(LPS) (Verhasselt et al, 1997), these precursor DC migrate to T cell
zones of lymph nodes (Macatonia et al, 1987; Kripke et al, 1990) and
mature into effective APC by ceasing endocytosis as well as their
processing function, stabilizing expression of class II-peptide complexes
(Kampgen et al, 1991; Stossel et al, 1990), and increasing expression of
CD80 or CD86 (Romani et al, 1989b; Symington et al, 1993;
Girolomoni et al, 1994; Ozawa et al, 1996). Other than LPS, DC have
been reported to be activated by some bacteria like Staphylococcus
aureus (Heufler et al, 1996) and Mycobacterium tuberculosis
(Henderson et al, 1997) via an unknown mechanism, and by phago-
cytosis of microparticle-adsorbed protein (Scheicher et al, 1995),
or apoptotic bodies (Rubartelli et al, 1997). These studies clearly
demonstrated the crucial role played by DC in innate immunity to
microorganisms.
Other than immunity to microorganisms, however, the immune
system also responds to simple chemicals. Allergic contact hypersensitiv-
ity reaction is a good example of the immune response to simple
chemicals. In this paper, we demonstrate that the activation and
apoptosis of DC are directly induced by some restricted simple
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Figure 1. The instructive role of innate
immunity played by DC in the acquired
immune response to infectious agents.
Immature DC are stimulated by infectious
microorganisms via pattern-recognition
receptors, and augment their expression of
costimulatory molecules and secretion of pro-
inflammatory cytokines. These mature DC
can stimulate naı¨ve T cells and induce specific
immunity to microorganisms.
Figure 2. Treatment with NiCl2 or DNCB augments the expression of CD86 on cultured monocyte-derived DC. CD1a1 DC were cultured with or
without several chemicals for 2 d. Their surface phenotypes were analyzed by flow cytometry. Data are expressed in the form of a fluorescence histogram overlay
depicting the staining of cells treated with specific chemicals (thick solid line), that without any chemicals (shaded curve), and the negative control staining (dotted
line). (Reproduced with permission from Aiba et al, 1997.)
chemicals, and we suggest that DC, as cells involved in the innate
immune system, play a crucial role in the immunity to simple chemicals.
MATERIALS AND METHODS
Media and reagents The medium used throughout the study was RPMI-
1640 including 25 mM N-2-hydroxyethylpiperazine-N1–2-ethanesulfonic acid
buffer solution (HEPES) (Sigma, St. Louis, MO) supplemented with 2 mM
L-glutamine, 1 mM sodium pyruvate, 1% penicillin, streptomycin and fungizone
antibiotic solution (Sigma), and 10% fetal calf serum (Summit Biotechnology)
(complete medium). The following chemicals were used for stimulation of DC:
nickel chloride (NiCl2), cobalt chloride (CoCl2), manganese chloride (MnCl2),
zinc chloride (ZnCl2), and sodium lauryl sulfate (SLS) from Sigma, 2,4-
dinitrochlorobenzene (DNCB) and cupric chloride from Wako Pure Chemicals
(Osaka, Japan), 2,4,6-trinitrochlorobenzene (TNCB) from Tokyo Kasei (Tokyo,
Japan), and 10% benzalkonium chloride (BC) solution from Japan Pharmaceutical
(Tokyo, Japan). We used the following monoclonal antibodies (MoAb) for
immunostaining: FITC-conjugated anti-CD80, anti-CD86, and anti-CD40 Ab
(PharMingen, San Diego, CA), FITC-conjugated anti-CD54 Ab (Ancell,
Bayport, MN), FITC- and PE-conjugated anti-HLA-DR Ab (Becton-
Dickinson, San Jose, CA), PE-conjugated anti-CD1a Ab (Coulter, Hialeah,
FL), FITC and PE-conjugated isotype-matched mouse control Ab (IgG2a and
IgG2b) (PharMingen). For examining the effects of cytokines on surface
molecule expression by DC, we used rabbit anti-IL-1β Ab, anti-TNFα Ab
(Genzyme, Cambridge, MA), and nonimmunized rabbit serum (Sigma). MACS
colloidal supermagnetic microbeads conjugated with monoclonal antihuman
CD14 Ab (CD14 microbeads) were purchased from Mitenyi Biotec (Sunnyvale,
CA). Recombinant human GM-CSF (rhGM-CSF) was a gift from Kirin
Brewery (Tokyo, Japan), and recombinant human IL-4 (rhIL-4) and anti-
TNFα (rhTNFα) were purchased from Genzyme (Cambridge, MA). DNCB
and TNCB were solubilized in dimethyl sulfoxide (DMSO) at a concentration
of 1 M. The final concentration of DMSO used was always at less than 0.1%.
Culture of DC from the peripheral blood monocytes (PBMC) PBMC
were obtained by Ficoll-Paque (Pharmacia, Uppsala, Sweden) gradient centrifu-
gation of heparinized fresh leukocyte-enriched buffy coats from different donors.
Purification of CD141 monocytes was performed by using MACS CD14
microbeads and a magnetic cell separator, MACS (Mitenyi Biotec), according
to the manufacturer’s protocol. Before culturing, we examined the percentages
of CD141 cells in those preparations by flow cytometry, and used cell specimens
containing more than 98% CD141 cells in the following experiments.
These CD141 monocytes (2 3 106 per ml) were cultured in the complete
medium containing 50 ng rhGM-CSF per ml and 100 ng rhIL-4 per ml for
5 d. Before the following chemical treatment, the cultured cells were examined
for the expression of CD1a by flow cytometry.
Chemical treatment of cultured DC Five days after the culture with GM-
CSF and IL-4, the cultured cells were treated with various concentrations of
NiCl2, CoCl2, MnCl2, CuCl2, ZnCl2, SLS, BC, DNCB, or TNCB for 24 h
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Figure 3. DC treated with NiCl2 or DNCB augment their expression of CD86 or HLA-DR antigen. DC from five to 14 subjects were treated with
several chemicals for 2 d, and their surface phenotypes were analyzed by flow cytometry. Relative fluorescence intensity (fold increase over control) was defined
by the following formula:
Relative fluorescence intensity (fold increase over control) 5
(Mean fluorescence intensity of DC treated with chemical) 4 (Mean fluorescence intensity of nontreated DC)
Relative fluorescence intensities are expressed on DC treated with each chemical. (Reproduced with permission from Aiba et al, 1997.)
or 48 h. In some experiments, in addition to chemicals, an optimal concentration
of the respective neutralizing Ab for IL-1β or for TNFα, or nonimmunized
rabbit serum used as a control, was added to the culture.
Flow cytometry Twenty-four and 48 h after treatment with chemicals, the
surface expression of HLA-DR and costimulatory molecules was analyzed by
a FACScan using the CellQuest program (Becton-Dickinson). Dead cells were
gated out with a final concentration of 0.5 mg propidium iodide solution per
ml. In some experiments, we calculated relative fluorescence intensity (fold
increase over control) by the following formula:
equation
Relative fluorescence intensity (fold increase over control) 5 (Mean fluores-
cence intensity of DC treated with chemicals) 4 (Mean fluorescence intensity
of nontreated DC)
ELISA for cytokine production The culture supernatant of the DC treated
with various chemicals was recovered 24 h and 48 h after culture. The
production of IL-1β, IL-6, and TNFα was measured by ELISA (R&D
Systems, Minneapolis, MN), using 96 well microtiter plates, according to the
manufacturer’s instructions.
Detection of apoptosis For annexin V staining, DC at different time
intervals after treatment with chemicals were washed with phosphate-buffered
saline, stained for annexin V-FITC and propidium iodide (Clontech Laboratories,
Palo Alto, CA) according to the manufacturer’s protocol, and analyzed by
flow cytometry.
For the in situ end-labeling technique [terminal deoxynucleotide transferase
(TdT) dUTP fluorescein nick end labeling (TUNEL)], an in situ apoptosis
detection kit from Oncor (Gaithersburg, MD) was used according to the
manufacturer’s protocol, and analysis was done by flow cytometry.
Statistical analysis The statistical significance in the upregulation of mean
fluorescence intensity of costimulatory molecule expression or HLA-DR antigen
measured in flow cytometry, or in the amount of secreted cytokines, was
analyzed using the Wilcoxon signed-rank test between nontreated DC and DC
treated with chemicals.
RESULTS AND DISCUSSION
Augmented expression of CD86 and increased production of
either IL-1b or TNFa by DC treated with chemicals in vitro
Although to induce T cell mediated immunity to protein antigens, so-
called adjuvants are required to activate the innate immune system
including DC, allergic contact hypersensitivity reaction does not require
such help by adjuvants, and can be induced by simple application of
haptens to the skin. When we consider the immunity to simple
chemicals by analogy with the immunity to infectious agents, innate
immunity should also play a role in it. DC or macrophages may
discriminate innocuous and noxious chemicals and trigger T cell
immunity. Indeed, by painting various chemicals on murine ears to
examine the expression of class II MHC antigens and costimulatory
molecules, we have demonstrated that Langerhans cells discriminate
some chemicals. They respond to chemicals that are classified as
haptens, i.e., dinitrochlorobenzene (DNCB), trinitrochlorobenzene
(TNCB), dinitrofluorobenzene (DNFB), and cinnamic aldehyde, but
not to primary irritants like benzalkonium, methyl salicylate, or phenol,
which induce irritation of the skin, by augmenting their expression of
class II MHC antigen and CD80 and CD86 (Aiba and Katz, 1990;
Ozawa et al, 1996). Enk et al found that the increase in Langerhans
cell-derived IL-1β mRNA signal strength is the first event in Langerhans
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Figure 4. DC treated with NiCl2 or DNCB increase their secretion of pro-inflammatory cytokines. DC from six to 11 subjects were treated with several
chemicals for 2 d, and the culture supernatants were measured for IL-1β, TNFα, and IL-6 by ELISA. (Reproduced with permission from Aiba et al, 1997.)
cells after hapten painting (Enk and Katz, 1992a), and that the cutaneous
injection of IL-1β results in increased expression of MHC class II Ag
and enhanced antigen-presenting function by Langerhans cells (Enk
et al, 1993). These data strongly suggest that DC recognize a difference
in chemicals, and subsequently determine their activation by themselves.
Because the skin also contains cells other than Langerhans cells, i.e.,
keratinocytes, mast cells, endothelial cells, and even T cells, however,
it is indispensable to examine this interaction between DC and
chemicals by using pure cultured DC, which can be kept in the
immature state and made to mature with appropriate stimuli in vitro.
The culture system of Langerhans cells is not suitable for this purpose
because they can fully mature in an in vitro culture system without
exogenous factors (Schuler and Steinman, 1985). Recently, Sallusto
and Lanzavecchia (1994) and Romani et al (1994) have reported that
immature DC can be obtained from a culture of peripheral blood
monocytes with GM-CSF and IL-4.
Using this culture system, we examined the effects of the following
chemicals on the expression of costimulatory molecules, CD1a, and
HLA-DR antigen, by DC: NiCl2, ZnCl2, MnCl2, CoCl2, CuCl2,
SLS, BC, TNCB, and DNCB. Figure 2 is a representative flow
cytometric profile of DC from one subject, and Fig 3 summarizes the
effects of the chemicals on DC from different subjects. When we
added these chemicals to the DC, we at first found that both
NiCl2 and DNCB, representative haptens, significantly increased the
expression of CD54, CD86, and HLA-DR antigen on DC compared
with that on nontreated controls or with that on DC treated with
ZnCl2, SLS, or BC, used as irritants. The increased expression of
CD86 was accompanied by augmented expression of its mRNA
demonstrated by reverse transcriptase-polymerase chain reaction (data
not shown). In addition, the augmented expression of CD86 by DC
treated with NiCl2 or DNCB was accompanied by their increased
secretion of either IL-1β or TNFα (Fig 4). These observations strongly
suggest that DC respond to simple chemicals such as NiCl2 or DNCB
by changing their expression of costimulatory molecules or HLA-
DR antigen and production of cytokines, subsequently altering their
antigen-presenting function. Indeed, we observed that DC treated
with NiCl2 or DNCB significantly augmented their allogeneic T cell
stimulatory function, which was dependent on their increased CD54
and CD86 expression (Fig 5). Although the numbers of subjects we
examined were limited, we also found that MnCl2 and CuCl2 exerted
effects on DC similar to those of NiCl2 and ZnCl2, respectively.
Different mechanisms of DC activation by NiCl2 and by
DNCB Next, to clarify the mechanism by which NiCl2 or DNCB
stimulated DC, we studied the effects of Ab for IL-1β and TNFα on
the upregulation of CD86 expression by DC treated with NiCl2 or
DNCB. Figure 6 shows representative data concerning the effects of
anticytokine antibodies on CD86 expression by DC treated with
Figure 5. DC treated with NiCl2 or DNCB augment allogeneic T cell
stimulatory function of DC, which was suppressed by anticostimulatory
molecule Ab. T cells (2 3 105 cells per well) were cocultured in 96 well flat-
bottom microtiter plates with various numbers of DC with or without chemical
treatment for 4 d at 37°C in a 5% CO2 humidified atmosphere. During the
last 16 h of culture, the cells were pulsed with 1 mCi [3H]-TdR per well (A).
To examine the role of CD54, CD80, or CD86 on allogeneic T cell stimulation
by DC, 10 mg per ml of monoclonal anti-CD54 Ab, anti-CD80 Ab, or anti-
CD86 Ab was added to the culture (B). (Reproduced with permission from
Aiba, 1998.)
DNCB or NiCl2. Statistical analysis of 15 different experiments
demonstrated that the augmented expression of CD86 on DC treated
with DNCB was suppressed by either the antibody for IL-1β (p 5
0.046) or that for TNFα (p 5 0.0150), whereas the augmentation
induced by NiCl2 was relatively insensitive to this antibody treatment.
This observation suggests that different chemicals induce CD86 expres-
sion on DC via different mechanisms. That is, DNCB at first stimulates
DC to secrete IL-1β or TNFα, which induces their CD86 expression.
On the other hand, NiCl2 may directly induce the augmentation of
CD86 expression on DC. In fact, we found that, consistent with this
observation, NiCl2 and DNCB induced several different responses in
DC. DC from a large number of subjects responded to NiCl2 by
increasing their expression of CD54 and HLA-DR antigen more
strongly than DC treated with DNCB, whereas both chemicals induced
similar magnitudes of upregulation of CD86. Although DC treated
with NiCl2 and DNCB increased their production of IL-1β, only
those treated with NiCl2 increased their production of IL-6 and TNFα.
Regarding the effects of DNCB, these data are consistent with the
observations by Enk et al (Enk and Katz, 1992a, b), which suggested
the production of IL-1β by Langerhans cells treated with haptens and
its crucial role in Langerhans cell maturation, although in our system
TNFα seemed to exert more dramatic effects on Langerhans cell
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Figure 6. Anti-TNFa Ab abrogates the augmentation of CD86
expression on DC treated with DNCB, but not that on those treated
with NiCl2. Anti-TNFα Ab or isotype-matched control Ab was added to the
culture of DC treated with NiCl2 or DNCB. The effects were analyzed by
flow cytometry. Data are expressed in the form of a fluorescence histogram
overlay depicting the staining of DC treated with NiCl2 or DNCB (thick solid
line), that with anti-TNFα Ab (thin solid line), that with isotype-matched
control Ab (broken line), and that of nontreated DC (dotted line).
Figure 7. The treatment with NiCl2 induces propidium iodide-negative
(PI–) and annexin V-FITC-positive (annexin V1) DC. DC at different
time intervals after treatment with chemicals were washed with phosphate-
buffered saline, stained for annexin V-FITC and propidium iodide according
to the manufacturer’s protocol, and analyzed by flow cytometry.
activation than IL-1β. The effects of NiCl2 on DC activation, however,
were totally different from their observations. Although NiCl2 increased
the production of IL-1β, the augmented expression of CD86 on DC
was not induced by the secreted IL-1β.
Apoptosis of DC To clarify the difference between the effects of
NiCl2 and DNCB on DC, apoptosis of DC was examined by two
different procedures, i.e., annexin V staining and the TUNEL method.
Figure 7 presents representative flow cytometry of annexin V staining
at 6 h after chemical application from five different experiments. NiCl2
could induce PI-annexin V1 cells, putative apoptotic cells, in the
concentration range from 1 to 10 mM, which was higher than the
optimal concentration to induce DC maturation. On the other hand,
DNCB or TNCB could not induce apoptosis in DC at any of the
concentrations we examined. Consistent with these data, the TUNEL
method also demonstrated TUNEL1 apoptotic cells in DC treated
with NiCl2, but not in those treated with DNCB, at 24 h after
chemical application (Fig 8).
Possible cascade of DC recognition in innate immunity to
simple chemicals These data clearly demonstrate that DC them-
selves recognize a difference in chemicals, and that those chemicals
Figure 8. NiCl2-induced TUNEL1 cells. Consistent with the data using
annexin V staining, only the treatment with NiCl2 resulted in TUNEL1 cells
in DC. Data are expressed in the form of a fluorescence histogram overlay
depicting the staining of DC treated with 9 mM NiCl2, 900 mM DNCB, or
900 mM TNCB (thick solid line), with 3 mM NiCl2, 300 mM DNCB,
or 300 mM TNCB (thin solid line), with 1 mM NiCl2, 100 mM DNCB, or
100 mM TNCB (broken line), and that of nontreated DC (shaded curve).
Figure 9. The instructive role of innate immunity played by DC in the
acquired immune responses to simple chemicals. Immature DC are
stimulated by certain simple chemicals and augment their expression of
costimulatory molecules and secretion of pro-inflammatory cytokines. These
mature DC can stimulate naı¨ve T cells and induce specific immunity to
chemicals. So far, however, the precise characteristics of the chemicals that can
activate DC and the mechanism by which DC respond to the chemicals
are unknown.
trigger their activation process and augment their expression of costimu-
latory molecules or class II MHC antigen and secretion of pro-
inflammatory cytokines (Fig 9). In addition, some chemicals trigger
their apoptosis. So far we do not know the precise reasons why the
chemicals stimulated DC, although some relationship between the
potential of chemicals to stimulate DC and that to sensitize animals is
suggested. We do not know either why only certain chemicals can
stimulate activation of DC. It is difficult to consider the possibility of
the presence of receptors to recognize these chemicals. The chemicals
that can activate DC do not necessarily share common chemical
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characteristics. It is conceivable that chemicals induce a stress response
that activates DC; however, because NiCl2 and DNCB induce DC
activation by different mechanisms and because different chemicals
induce heterogeneous responses in the augmentation of costimulatory
molecules or class II MHC antigen, that of cytokine secretion and
induction of apoptosis, the activation of DC cannot be explained by
a simple stress response. These chemicals may directly affect the
intracellular signal transduction of DC.
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